Pharmacological inhibition of autophagy weakened the atherosclerosis protection observed in Cav-1 mice by increasing endothelial inflammation and macrophage recruitment, thus identifying a new molecular mechanism for preventing atherosclerosis progression by Cav-1 deficiency. This evidence concerns the gene CAV1 and atherosclerosis.